Page last updated: 2024-10-25

chlorpyrifos and Minimal Disease, Residual

chlorpyrifos has been researched along with Minimal Disease, Residual in 3 studies

Chlorpyrifos: An organothiophosphate cholinesterase inhibitor that is used as an insecticide and as an acaricide.
chlorpyrifos : An organic thiophosphate that is O,O-diethyl hydrogen phosphorothioate in which the hydrogen of the hydroxy group has been replaced by a 3,5,6-trichloropyridin-2-yl group.

Research Excerpts

ExcerptRelevanceReference
"Flow cytometry is widely used for B-ALL minimal residual disease (MRD) analysis given its speed, availability, and sensitivity; however, distinguishing B-lymphoblasts from regenerative B-cells is not always straightforward."1.72Machine learning optimized multiparameter radar plots for B-cell acute lymphoblastic leukemia minimal residual disease analysis. ( Al-Bakri, M; Liu, L; Setiadi, A; Shopsowitz, KE; Vercauteren, S, 2022)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Shopsowitz, KE1
Liu, L1
Setiadi, A1
Al-Bakri, M1
Vercauteren, S1
Bento, LC1
Correia, RP1
de Sousa, FA1
Bacal, NS1
Cox, CE1
Russell, S1
Prowler, V1
Carter, E1
Beard, A1
Mehindru, A1
Blumencranz, P1
Allen, K1
Portillo, M1
Whitworth, P1
Funk, K1
Barone, J1
Norton, D1
Schroeder, J1
Police, A1
Lin, E1
Combs, F1
Schnabel, F1
Toth, H1
Lee, J1
Anglin, B1
Nguyen, M1
Canavan, L1
Laidley, A1
Warden, MJ1
Prati, R1
King, J1
Shivers, SC1

Trials

1 trial available for chlorpyrifos and Minimal Disease, Residual

ArticleYear
A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision.
    Annals of surgical oncology, 2016, Volume: 23, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Female; Humans; Mammography; Margins of Excision;

2016

Other Studies

2 other studies available for chlorpyrifos and Minimal Disease, Residual

ArticleYear
Machine learning optimized multiparameter radar plots for B-cell acute lymphoblastic leukemia minimal residual disease analysis.
    Cytometry. Part B, Clinical cytometry, 2022, Volume: 102, Issue:5

    Topics: Acute Disease; Burkitt Lymphoma; Child; Flow Cytometry; Humans; Machine Learning; Neoplasm, Residual

2022
A novel approach for MRD assessment by high-sensitivity flow cytometry and multidimensional radar visualization.
    International journal of laboratory hematology, 2023, Volume: 45, Issue:4

    Topics: Flow Cytometry; Humans; Neoplasm, Residual; Radar

2023